Free Newsletter
Would-be partners wage angry feud
The angry exchanges between Emergent BioSolutions and Protein Sciences keep getting nastier. Both companies now accuse each other of breaking their $78 million merger pact, and the accusations are likely to continue to ring in an ongoing lawsuit. This week Emergent revised its offer for Protein Sciences, but Protein Sciences says the deal is off. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
